{
  "trial_id": "NCT01879579",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Initiating long-acting insulin treatment or initiating the titration of long-acting insulin treatment",
      "label": "met"
    },
    {
      "criterion": "Speaks English or Spanish",
      "label": "met"
    },
    {
      "criterion": "Hemoglobin A1c > or = 8%",
      "label": "unknown"
    },
    {
      "criterion": "Able and willing to inject insulin",
      "label": "met"
    },
    {
      "criterion": "Able and willing to provide informed consent",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Short-acting insulin treatment",
      "label": "not_met"
    },
    {
      "criterion": "Systemic glucocorticoids",
      "label": "unknown"
    },
    {
      "criterion": "Sustained elevated serum creatinine > or = 1.5 mg/dL for men and > or = 1.4 mg/dL for women",
      "label": "not_met"
    },
    {
      "criterion": "Hypoglycemia unawareness",
      "label": "unknown"
    },
    {
      "criterion": "Type 1 diabetes",
      "label": "met"
    }
  ],
  "notes": "Patient has type 1 diabetes and is initiating long-acting insulin treatment. He speaks English.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT01879579",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}